Rapport Therapeutics Inc.... (RAPP)
Rapport Therapeutics Common Stock Max Pain By Strike
RAPP trades at $28.54, 14.2% above the near-term max pain of $25 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($17.5-$25), reflecting growing call interest at higher strikes. Key magnetic zone at 25 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Rapport Therapeutics Common Stock Max Pain By Expiry
Max pain for RAPP shows an upward trend from 17.5 to 25, suggesting bullish positioning in longer-dated options. The 34% spread signals divergent expectations across timeframes. Most levels below 28.54 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 25 | n/a (n/a) |
| Nov 21, 2025 | 20 | n/a (n/a) |
| Feb 20, 2026 | 25 | n/a (n/a) |
| May 15, 2026 | 17.5 | n/a (n/a) |